Download PDF
Aktuelle Neurologie 2005; 32(7): 423-439
DOI: 10.1055/s-2004-834726
Fort- und Weiterbildung
© Georg Thieme Verlag KG Stuttgart · New York

Diagnose und Differenzialdiagnose der leichten kognitiven Beeinträchtigung

Diagnosis and Differential Diagnosis of Mild Cognitive ImpairmentB.  Heimann1 , C.-W.  Wallesch1
  • 1Klinik für Neurologie der Otto-von-Guericke-Universität Magdeburg
Further Information

Publication History

Publication Date:
29 August 2005 (online)

Also available at
    Permissions and Reprints

Weiterbildungsziele In diesem Beitrag sollen folgende Weiterbildungsziele vermittelt werden: Kenntnis des Störungsbildes Diagnose und Diagnosekriterien Differenzialdiagnose Stellenwert von Neuropsychologie und Bildgebung Prognose Problematik des nosologischen Konzeptes

Literatur

  • 1 Dubois B, Albert M L. Amnestic MCI or prodromal Alzheimer's disease?.  Lancet Neurol. 2004;  3 246-248
    PubMedGoogle Scholar
  • 2 Grady C L, Haxby J V, Horwitz B. et al . Longitudinal study of the early neuropsychological and cerebral metabolic changes in dementia of the Alzheimer type.  J Clin Exp Neuropsychol. 1988;  10 576-596
    PubMedGoogle Scholar
  • 3 Flicker C, Ferris S H, Reisberg B. Mild cognitive impairment in the elderly: predictors of dementia.  Neurology. 1991;  41 1006-1009
    CrossrefPubMedGoogle Scholar
  • 4 Petersen R C, Doody R, Kurz A. et al . Current concepts in mild cognitive impairment.  Arch Neurol. 2001;  58 1985-1992
    CrossrefPubMedGoogle Scholar
  • 5 Collie A, Maruff P. An analysis of systems of classifying mild cognitive impairment in older people.  Australian and New Zealand Journal of Psychiatry. 2002;  36 133-140
    CrossrefPubMedGoogle Scholar
  • 6 Busse A, Bischkopf J, Riedel-Heller S G. et al . Mild cognitive impairment: prevalence and incidence according to different diagnostic criteria. Results of the Leipzig Longitudinal Study of the Aged (LEILA75+).  Br J Psychiatry. 2003;  182 449-454
    CrossrefPubMedGoogle Scholar
  • 7 Kral V A. Senescent forgetfulness: benign and malignant.  Can Med Assoc J. 1962;  86 257-260
    PubMedGoogle Scholar
  • 8 Crook T, Bartus R, Ferris S H. et al . Age-assoziated memory impairment: Proposed diagnostic criteria and measures of clinical change: report of a National Institute of Mental Health Work Group.  Dev Neuropsychol. 1986;  2 261-276
    PubMedGoogle Scholar
  • 9 O'Brien J T, Levy R. Age associated memory impairment.  BMJ. 1992;  304 5-6
    PubMedGoogle Scholar
  • 10 Rosen T J. „Age-associated memory impairment”: a critique.  European J Cognitive Psychol. 1990;  2 275-287
    PubMedGoogle Scholar
  • 11 Saß H, Wittchen H-U, Zaudig M. Diagnostisches und Statistisches Manual Psychischer Störungen. Göttingen; Hogrefe-Verlag 1994
    Google Scholar
  • 12 Dilling H, Mombour W, Schmid M H. et al .Weltgesundheitsorganisation: Internationale Klassifikation psychischer Störungen. ICD-10. Bern, Göttingen, Toronto, Seattle; Huber 1994
    Google Scholar
  • 13 Petersen R C, Smith G E, Waring S C. et al . Mild cognitive impairment: clinical characterization and outcome.  Arch Neurol. 1999;  56 303-308
    CrossrefPubMedGoogle Scholar
  • 14 Morris J C, Storandt M, Miller J P. et al . Mild cognitive impairment represents early-stage Alzheimer disease.  Arch Neurol. 2001;  58 397-405
    CrossrefPubMedGoogle Scholar
  • 15 Tierney M C, Szalai J P, Snow W G. et al . Prediction of probable Alzheimer's disease in memory-impaired patients: a prospective longitudinal study.  Neurology. 1996;  46 661-665
    PubMedGoogle Scholar
  • 16 Shah Y, Tangalos E G, Petersen R C. Mild cognitive impairment.  When is it a precursor to Alzheimer's disease? Geriatrics. 2000;  55 62-68
    PubMedGoogle Scholar
  • 17 Busse A, Bischkopf J, Riedel-Heller S G. et al . Subclassifications for mild cognitive impairment: prevalence and predictive validity.  Psychol Med. 2003;  33 1029-1038
    CrossrefPubMedGoogle Scholar
  • 18 Jorm A F, Christensen H, Korten A E. et al . Memory complaints as a precursor of memory impairment in older people: a longitudinal analysis over 7 - 8 years.  Psychol Med. 2001;  31 441-449
    PubMedGoogle Scholar
  • 19 Jonker C, Geerlings M I, Schmand B. Are memory complaints predictive for dementia? A review of clinical and population-based studies.  Int J Geriatr Psychiatry. 2000;  15 983-991
    CrossrefPubMedGoogle Scholar
  • 20 Smith G E, Petersen R C, Ivnik R J. et al . Subjective memory complaints, psychological distress, and longitudinal change in objective memory performance.  Psychol Aging. 1996;  11 272-279
    CrossrefPubMedGoogle Scholar
  • 21 Jorm A F, Scott R, Jacomb P A. Assesment of cognitive decline in dementia by informant questionnaire.  Int J Geriatr Psychiatry. 1989;  4 35-39
    PubMedGoogle Scholar
  • 22 Folstein M F, Folstein S E, McHugh P R. „Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician.  J Psychiatr Res. 1975;  12 189-198
    CrossrefPubMedGoogle Scholar
  • 23 Ganguli M, Belle S, Ratcliff G. et al . Sensitivity and specificity for dementia of population-based criteria for cognitive impairment: the MoVIES project.  J Gerontol. 1993;  48 M152-M161
    PubMedGoogle Scholar
  • 24 Kukull W A, Larson E B, Teri L. et al . The Mini-Mental State Examination score and the clinical diagnosis of dementia.  J Clin Epidemiol. 1994;  47 1061-1067
    CrossrefPubMedGoogle Scholar
  • 25 Albert M S, Moss M B, Tanzi R. et al . Preclinical prediction of AD using neuropsychological tests.  J Int Neuropsychol Soc. 2001;  7 631-639
    CrossrefPubMedGoogle Scholar
  • 26 Jacobson N S, Truax P. Clinical significance: a statistical approach to defining meaningful change in psychotherapy research.  J Consult Clin Psychol. 1991;  59 12-19
    CrossrefPubMedGoogle Scholar
  • 27 Wolf H, Jelic V, Gertz H J. et al . A critical discussion of the role of neuroimaging in mild cognitive impairment.  Acta Neurol Scand Suppl. 2003;  179 52-76
    PubMedGoogle Scholar
  • 28 Leon M J de, Convit A, George A E. et al . In vivo structural studies of the hippocampus in normal aging an in incipient Alzheimer's disease.  Ann-N-Y-Acad-Science. 1996;  777 1-13
    PubMedGoogle Scholar
  • 29 Laakso M P, Soininen H, Partanen K. et al . MRI of the hippocampus in Alzheimer's disease: sensitivity, specificity, and analysis of the incorrectly classified subjects.  Neurobiology-of-aging. 1998;  19 23-31
    CrossrefPubMedGoogle Scholar
  • 30 Jack Jr C R, Petersen R C, Xu Y C. et al . Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment.  Neurology. 1999;  52 1397-1403
    CrossrefPubMedGoogle Scholar
  • 31 Korf E S, Wahlund L O, Visser P J. et al . Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment.  Neurology. 2004;  63 94-100
    PubMedGoogle Scholar
  • 32 Jack Jr C R, Petersen R C, Xu Y. et al . Rates of hippocampal atrophy correlate with change in clinical status in aging and AD.  Neurology. 2000;  55 484-489
    PubMedGoogle Scholar
  • 33 Burns A, Zaudig M. Mild cognitive impairment in older people.  Lancet. 2002;  360 1963-1965
    CrossrefPubMedGoogle Scholar
  • 34 Drzezga A, Lautenschlager N, Siebner H. et al . Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study.  Eur J Nucl Med Mol Imaging. 2003;  30 1104-1113
    CrossrefPubMedGoogle Scholar
  • 35 Chetelat G, Desgranges B, Sayette V De la. et al . Mild cognitive impairment: Can FDG-PET predict who is to rapidly convert to Alzheimer's disease.  Neurology. 2003;  60 1374-1377
    CrossrefPubMedGoogle Scholar
  • 36 Hampel H, Goernitz A, Buerger K. Advances in the development of biomarkers for Alzheimer's disease: from CSF total tau and Abeta(1 - 42) proteins to phosphorylated tau protein.  Brain Res Bull. 2003;  61 243-253
    CrossrefPubMedGoogle Scholar
  • 37 Schoonenboom N S, Pijnenburg Y A, Mulder C. et al . Amyloid beta(1 - 42) and phosphorylated tau in CSF as markers for early-onset Alzheimer disease.  Neurology. 2004;  62 1580-1584
    PubMedGoogle Scholar
  • 38 Maruyama M, Matsui T, Tanji H. et al . Cerebrospinal fluid tau protein and periventricular white matter lesions in patients with mild cognitive impairment: implications for 2 major pathways.  Arch Neurol. 2004;  61 716-720
    CrossrefPubMedGoogle Scholar
  • 39 Buerger K, Teipel S J, Zinkowski R. et al . CSF tau protein phosphorylated at threonine 231 correlates with cognitive decline in MCI subjects.  Neurology. 2002;  59 627-629
    PubMedGoogle Scholar
  • 40 Zetterberg H, Wahlund L O, Blennow K. Cerebrospinal fluid markers for prediction of Alzheimer's disease.  Neurosci Lett. 2003;  352 67-69
    CrossrefPubMedGoogle Scholar
  • 41 Arai H, Ishiguro K, Ohno H. et al . CSF phosphorylated tau protein and mild cognitive impairment: a prospective study.  Exp Neurol. 2000;  166 201-203
    CrossrefPubMedGoogle Scholar
  • 42 Andreasen N, Vanmechelen E, Vanderstichele H. et al . Cerebrospinal fluid levels of total-tau, phospho-tau and A beta 42 predicts development of Alzheimer's disease in patients with mild cognitive impairment.  Acta Neurol Scand Suppl. 2003;  179 47-51
    PubMedGoogle Scholar
  • 43 Andreasen N, Minthon L, Vanmechelen E. et al . Cerebrospinal fluid tau and Abeta42 as predictors of development of Alzheimer's disease in patients with mild cognitive impairment.  Neurosci Lett. 1999;  273 5-8
    CrossrefPubMedGoogle Scholar
  • 44 Blennow K. CSF biomarkers for mild cognitive impairment.  J Intern Med. 2004;  256 224-234
    CrossrefPubMedGoogle Scholar
  • 45 Christensen H, Griffiths K, Mackinnon A. et al . A quantitative review of cognitive deficits in depression and Alzheimer-type dementia.  J Int Neuropsychol Soc. 1997;  3 631-651
    PubMedGoogle Scholar
  • 46 Robbins T W, Elliott R, Sahakian B J. Neuropsychology - dementia and affective disorders.  Br Med Bull. 1996;  52 627-643
    PubMedGoogle Scholar
  • 47 Visser P J, Verhey F R, Ponds R W. et al . Distinction between preclinical Alzheimer's disease and depression.  J Am Geriatr Soc. 2000;  48 479-484
    PubMedGoogle Scholar
  • 48 Rubin E H, Kinscherf D A. Psychopathology of very mild dementia of the Alzheimer type.  Am J Psychiatry. 1989;  146 1017-1021
    PubMedGoogle Scholar
  • 49 Robbins T W, Elliott R, Sahakian B J. Neuropsychology - dementia and affective disorders.  Br Med Bull. 1996;  52 627-643
    PubMedGoogle Scholar
  • 50 Geerlings M I, Schoevers R A, Beekman A T. et al . Depression and risk of cognitive decline and Alzheimer's disease. Results of two prospective community-based studies in The Netherlands.  Br J Psychiatry. 2000;  176 568-575
    CrossrefPubMedGoogle Scholar
  • 51 Nygard L. Instrumental activities of daily living: a stepping-stone towards Alzheimer's disease diagnosis in subjects with mild cognitive impairment?.  Acta Neurol Scand Suppl. 2003;  179 42-46
    PubMedGoogle Scholar
  • 52 Hughes C P, Berg L, Danziger W L. et al . A new clinical scale for the staging of dementia.  Br J Psychiatry. 1982;  140 566-572
    CrossrefPubMedGoogle Scholar
  • 53 Reisberg B, Ferris S H, Leon M J de. et al . The global deterioration scale (GDS): an instrument for the assessment of primary degenerative dementia (PDD).  Am J Psychiatry. 1982;  139 1135-1139
    PubMedGoogle Scholar
  • 54 Davis H S, Rockwood K. Conceptualization of mild cognitive impairment: a review.  Int J Geriatr Psychiatry. 2004;  19 313-319
    PubMedGoogle Scholar
  • 55 Ingles J L, Wentzel C, Fisk J D. et al . Neuropsychological predictors of incident dementia in patients with vascular cognitive impairment, without dementia.  Stroke. 2002;  33 1999-2002
    CrossrefPubMedGoogle Scholar
  • 56 Wentzel C, Rockwood K, MacKnight C. et al . Progression of impairment in patients with vascular cognitive impairment without dementia.  Neurology. 2001;  57 714-716
    PubMedGoogle Scholar
  • 57 Luca C R De, Wood S J, Anderson V. et al . Normative data from the CANTAB. I: development of executive function over the lifespan.  J Clin Exp Neuropsychol. 2003;  25 242-254
    PubMedGoogle Scholar
  • 58 Mast R C van der, Broek W W van den, Fekkes D. et al . Incidence of and preoperative predictors for delirium after cardiac surgery.  J Psychosom Res. 1999;  46 479-483
    Google Scholar
  • 59 Rockwood K. The occurence and duration of symptoms in elderly patients with delirium.  J Gerontol. 1993;  48 162-166
    PubMedGoogle Scholar
  • 60 Francis J, Kapoor W N. Prognosis after hospital discharge of older medical patients with delirium.  J Am Geriatr Soc. 1992;  40 601-606
    CrossrefPubMedGoogle Scholar
  • 61 Newman M F, Kirchner J L, Phillips-Bute B. et al . Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery.  N Engl J Med. 2001;  344 395-402
    CrossrefPubMedGoogle Scholar
  • 62 McKhann G M, Borowicz L M, Goldsborough M A. et al . Depression and cognitive decline after coronary artery bypass grafting.  Lancet. 1997;  349 1282-1284
    CrossrefPubMedGoogle Scholar
  • 63 Raja P V, Blumenthal J A, Doraiswamy P M. Cognitive deficits following coronary artery bypass grafting: prevalence, prognosis, and therapeutic strategies.  CNS Spectr. 2004;  9 763-772
    PubMedGoogle Scholar
  • 64 Selnes O A, Royall R M, Grega M A. et al . Cognitive changes 5 years after coronary artery bypass grafting: is there evidence of late decline?.  Arch Neurol. 2001;  58 598-604
    CrossrefPubMedGoogle Scholar
  • 65 Ho P M, Arciniegas D B, Grigsby J. et al . Predictors of cognitive decline following coronary artery bypass graft surgery.  Ann Thorac Surg. 2004;  77 597-603
    CrossrefPubMedGoogle Scholar
  • 66 Selnes O A, Grega M A, Borowicz Jr L M. et al . Cognitive changes with coronary artery disease: a prospective study of coronary artery bypass graft patients and nonsurgical controls.  Ann Thorac Surg. 2003;  75 1377-1384
    CrossrefPubMedGoogle Scholar
  • 67 Kurz A, Diehl J, Riemenschneider M. et al . Leichte kognitive Störung, Fragen zu Definition, Diagnose, Prognose und Therapie.  Nervenarzt. 2004;  75 6-15
    CrossrefPubMedGoogle Scholar
  • 68 Allain H, Bentue-Ferrer D, Akwa Y. Mild cognitive impairment: a treatment at last?.  Lancet Neurol. 2004;  3 643
    PubMedGoogle Scholar
  • 69 Voisin T, Touchon J, Vellas B. Mild cognitive impairment: a nosological entity?.  Curr Opin Neurol. 2003;  16, Suppl 2 S43-S45
    PubMedGoogle Scholar
  • 70 Zimmermann P, Fimm B. Testbatterie zur Aufmerksamkeitsprüfung (TAP) Version 1.7. Herzogenrath; Psytest 2002
    Google Scholar
  • 71 Thalmann B, Monsch A U, Bernasconi F. et al .Die CERAD Neuropsychologische Testbatterie. Ein gemeinsames minimales Instrumentarium zur Demenzabklärung. Basel; Memory Clinic 1998
    Google Scholar
  • 72 Härting C, Markowitsch H J, Neufeld H. et al .Wechsler Gedächtnistest - Revidierte Fassung. Dt. Adaptation der revidierten Fassung der Wechsler Memory Scale. Bern; Hans Huber 2000
    Google Scholar
  • 73 Helmstaedter C, Lendt M, Lux S. Verbaler Lern- und Merkfähigkeitstest. Göttingen; Beltz Test 2001
    Google Scholar
  • 74 Gagnon M, Awad N, Mertens V B. et al . Comparing the Rey and Taylor complex figures: a test-retest study in young and older adults.  J Clin Exp Neuropsychol. 2003;  25 878-890
    PubMedGoogle Scholar
  • 75 Tewes U. Hamburg-Wechsler Intelligenztest für Erwachsene - Revision (2. korr. Aufl.). Göttingen; Hogrefe 1991
    Google Scholar
  • 76 Aschenbrenner S, Tucha O, Lange K W. RWT - Regensburger Wortflüssigkeits-Test. Göttingen; Hogrefe 2000
    Google Scholar
  • 77 Osswald W D, Fleischmann U M. Das Nürnberger Altersinventar (NAI) (4. Aufl.). Göttingen; Hogrefe 1997
    Google Scholar
  • 78 Glindemann R, Klintwort D, Ziegler W. et al .Bogenhausener Semantik-Untersuchung BOSU. München; Urban & Fischer 2002
    Google Scholar

Dipl.-Psych. B. Heimann

Sektion Neuropsychologie der Klinik für Neurologie · Universitätsklinik Magdeburg

Leipziger Straße 44

39120 Magdeburg

Email: birgit.heimann@medizin.uni-magdeburg.de

      >